NeuroSense Therapeutics Ltd. Warrant (NRSNW) is a publicly traded the market company. As of September 12, 2026, NRSNW trades at $0.18 with a market cap of $0 and a P/E ratio of 0.00. NRSNW moved +0.00% today. Year to date, NRSNW is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces NRSNW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NeuroSense Therapeutics Ltd. Warrant (NRSNW) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NRSNW moved +0.00% today.
| Metric | Value |
|---|---|
| Price | $0.18 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
NRSNW analyst coverage data. Average price target: $0.00.